Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient

被引：0
作者：
Rosenfeld, SB
Watkinson, KK
Thompson, BH
Macfarlane, DE
Lentz, SR
机构：
[1] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA
[3] Great Plains Reg Hemophilia Treatment Ctr, Iowa City, IA USA
[4] Vet Affairs Med Ctr, Iowa City, IA 52242 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 2002年 / 87卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：925 / 926
页数：2
相关论文
共 6 条
[1]   Adverse reactions related to rVIIa? [J].
Aledort, LM .
AMERICAN JOURNAL OF HEMATOLOGY, 2001, 67 (03) :213-213
[2]  
Ewenstein BM, 2001, THROMB HAEMOSTASIS, V86, P942
[3]   New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate [J].
Kessler, CM .
CURRENT OPINION IN HEMATOLOGY, 2000, 7 (06) :408-413
[4]  
KEY NS, 2001, BLOOD, V96, pA519
[5]  
Monroe DM, 1998, BLOOD COAGUL FIBRIN, V9, pS15
[6]   Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa [J].
van't Veer, C ;
Golden, NJ ;
Mann, KG .
BLOOD, 2000, 95 (04) :1330-1335
1